DNAnexus Adds Jovan Willford to Board of Directors
Veteran healthcare technology executive brings decades of operational experience applying advanced data analytics to enable the healthcare ecosystem.
Parse Biosciences Announces Cloud Analysis Platform to Simplify Single Cell Analysis
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a new cloud analysis solution to simplify the analysis of single cell RNA sequencing (scRNA-seq). The new cloud analysis platform will provide an accessible option for researchers to analyze scRNA-seq data without required bioinformatics experience. The new solution is a direct result of a co-development collaboration between Parse Biosciences and DNAnexus, the leading provider of cloud-based genomic and biomedical data access and companion analysis software.Read More
DNAnexus to Showcase Platform Scalability, Versatility, and Security at ASHG 2022 Annual Meeting
DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the speaker lineup for its customer presentations at the American Society of Human Genetics (ASHG) 2022 Annual Meeting, which is being held in Los Angeles this week. The company will also be showcasing its GxP-compliant platform and new Nextflow pipeline language support capabilities in booth #2103.Read More
DNAnexus Adds Jeff Margolis to Board of Directors
DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the appointment of Jeff Margolis, a seasoned healthcare information technology executive and current Senior Advisor for Blackstone (NYSE:BX), to its Board of Directors. The appointment follows the company’s $200 million financing round, which was led by Blackstone.Read More
DNAnexus Appoints Chief Commercial Officer to Accelerate Global Adoption of Leading Biomedical Data-Driven Technology Platform
DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the appointment of Stephen Nuckols as Chief Commercial Officer. The appointment follows the company’s recent $200 million financing round, which was led by Blackstone. Nuckols will be responsible for building on the company’s success, driving its commercial growth strategy, and leading its sales, solution science, and marketing functions.Read More
DNAnexus included in Fast Company's 10 most innovative biotech companies of 2023
Among the 2023 Most Innovative Companies in Biotech, Fast Company is recognizing breakthroughs in DNA sequencing and spatial transcriptomics, along with innovations in biological-specimen sourcing, cell-separation technology, and the production of synthetic antibodies.
Blackstone Growth Leads $200 Million Investment in DNAnexus
DNAnexus, founded in 2010, has a platform that puts massive sets of genomic data into the cloud so they can be accessed and analyzed by researchers who may be unable to process that volume onsite.Read More
"Collaboration is vital to advancing scientiﬁc discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward ﬁnding cures for pediatric cancer and other life-threatening diseases."
James R. Downing
President & CEO
St. Judes Children’s Research Hospital